Blaine Davis - 06 Jan 2026 Form 4 Insider Report for Cartesian Therapeutics, Inc. (RNAC)

Role
Chief Financial Officer
Signature
/s/ Matthew Bartholomae, Attorney-in-Fact for Blaine Davis
Issuer symbol
RNAC
Transactions as of
06 Jan 2026
Net transactions value
-$72,227
Form type
4
Filing time
08 Jan 2026, 16:19:50 UTC
Previous filing
06 Jan 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Davis Blaine Chief Financial Officer C/O CARTESIAN THERAPEUTICS, INC., 7495 NEW HORIZON WAY, FREDERICK /s/ Matthew Bartholomae, Attorney-in-Fact for Blaine Davis 08 Jan 2026 0001802188

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RNAC Common Stock Sale $72,227 -10,591 -8% $6.82 121,220 06 Jan 2026 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares sold to satisfy withholding tax obligations upon the vesting of restricted stock units and to cover related broker fees.